PubMed:9076517
Annnotations
GlyCosmos15-Species
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| 19 | 144-152 | Species | denotes | patients | 9606 |
| 22 | 457-465 | Species | denotes | patients | 9606 |
| 24 | 497-505 | Species | denotes | patients | 9606 |
| 27 | 557-565 | Species | denotes | patients | 9606 |
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 334-337 | Glycan_Motif | denotes | Leb | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G39211DH |
Glycosmos6-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 52-56 | http://www.glycoepitope.jp/epitopes/AN0514 | denotes | YB-2 |
| T2 | 293-297 | http://www.glycoepitope.jp/epitopes/AN0514 | denotes | YB-2 |
| T3 | 836-840 | http://www.glycoepitope.jp/epitopes/AN0514 | denotes | YB-2 |
| T4 | 889-893 | http://www.glycoepitope.jp/epitopes/AN0514 | denotes | YB-2 |
| T5 | 912-916 | http://www.glycoepitope.jp/epitopes/AN0514 | denotes | YB-2 |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-99 | Sentence | denotes | The usefulness of anti-fucosylated antigen antibody YB-2 for diagnosis of hepatocellular carcinoma. |
| TextSentencer_T2 | 100-360 | Sentence | denotes | Levels of fucosylated antigens in sera from patients with liver diseases were examined by a newly developed sandwich-type enzyme immuno assay with the aid of anti-fucosylated antigen antibody, YB-2 which reacts simultaneously with Y, Leb and H type 2 antigens. |
| TextSentencer_T3 | 361-687 | Sentence | denotes | When the cut-off value was set arbitrarily at mean +3 SD values of normal, 30 (69.8%) of the 43 patients with HCC, 14 (53.8%) of the 26 patients with liver cirrhosis (LC) and 24 (45.3%) of the 53 patients with chronic hepatitis (CH) were found to be positive, whereas all of the 30 samples from healthy controls were negative. |
| TextSentencer_T4 | 688-850 | Sentence | denotes | The levels of alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) in HCC were not correlated with those of YB-2 antigens. |
| TextSentencer_T5 | 851-1121 | Sentence | denotes | The positive rates of the combination YB-2 and AFP assay and YB-2 and PIVKA-II assay in HCC were significantly higher (83.7 and 86.0%, respectively) than that of the AFP and PIVKA-II combination (65.1%) which had been reported to be the best combination up to this time. |
| T1 | 0-99 | Sentence | denotes | The usefulness of anti-fucosylated antigen antibody YB-2 for diagnosis of hepatocellular carcinoma. |
| T2 | 100-360 | Sentence | denotes | Levels of fucosylated antigens in sera from patients with liver diseases were examined by a newly developed sandwich-type enzyme immuno assay with the aid of anti-fucosylated antigen antibody, YB-2 which reacts simultaneously with Y, Leb and H type 2 antigens. |
| T3 | 361-687 | Sentence | denotes | When the cut-off value was set arbitrarily at mean +3 SD values of normal, 30 (69.8%) of the 43 patients with HCC, 14 (53.8%) of the 26 patients with liver cirrhosis (LC) and 24 (45.3%) of the 53 patients with chronic hepatitis (CH) were found to be positive, whereas all of the 30 samples from healthy controls were negative. |
| T4 | 688-850 | Sentence | denotes | The levels of alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) in HCC were not correlated with those of YB-2 antigens. |
| T5 | 851-1121 | Sentence | denotes | The positive rates of the combination YB-2 and AFP assay and YB-2 and PIVKA-II assay in HCC were significantly higher (83.7 and 86.0%, respectively) than that of the AFP and PIVKA-II combination (65.1%) which had been reported to be the best combination up to this time. |
GlyCosmos6-Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 334-337 | https://glytoucan.org/Structures/Glycans/G39211DH | denotes | Leb |
Glycosmos6-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 158-163 | http://purl.obolibrary.org/obo/MAT_0000097 | denotes | liver |
| T2 | 511-516 | http://purl.obolibrary.org/obo/MAT_0000097 | denotes | liver |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 74-98 | Disease | denotes | hepatocellular carcinoma | http://purl.obolibrary.org/obo/MONDO_0007256 |
| T2 | 158-172 | Disease | denotes | liver diseases | http://purl.obolibrary.org/obo/MONDO_0005154 |
| T3 | 471-474 | Disease | denotes | HCC | http://purl.obolibrary.org/obo/MONDO_0007256 |
| T4 | 511-526 | Disease | denotes | liver cirrhosis | http://purl.obolibrary.org/obo/MONDO_0005155 |
| T5 | 528-530 | Disease | denotes | LC | http://purl.obolibrary.org/obo/MONDO_0005155 |
| T6 | 571-588 | Disease | denotes | chronic hepatitis | http://purl.obolibrary.org/obo/MONDO_0002251 |
| T7 | 590-592 | Disease | denotes | CH | http://purl.obolibrary.org/obo/MONDO_0002251 |
| T8 | 798-801 | Disease | denotes | HCC | http://purl.obolibrary.org/obo/MONDO_0007256 |
| T9 | 939-942 | Disease | denotes | HCC | http://purl.obolibrary.org/obo/MONDO_0007256 |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 74-98 | Phenotype | denotes | hepatocellular carcinoma | HP:0001402 |
| T2 | 158-172 | Phenotype | denotes | liver diseases | HP:0001392 |
| T3 | 511-526 | Phenotype | denotes | liver cirrhosis | HP:0001394 |
| T4 | 528-530 | Phenotype | denotes | LC | HP:0001394 |
| T5 | 571-588 | Phenotype | denotes | chronic hepatitis | HP:0200123 |
| T6 | 590-592 | Phenotype | denotes | CH | HP:0200123 |
GlyCosmos15-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 74-98 | Phenotype | denotes | hepatocellular carcinoma | HP:0001402 |
| T2 | 158-172 | Phenotype | denotes | liver diseases | HP:0001392 |
| T3 | 511-526 | Phenotype | denotes | liver cirrhosis | HP:0001394 |
| T4 | 528-530 | Phenotype | denotes | LC | HP:0001394 |
| T5 | 571-588 | Phenotype | denotes | chronic hepatitis | HP:0200123 |
| T6 | 590-592 | Phenotype | denotes | CH | HP:0200123 |
GlyCosmos15-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-99 | Sentence | denotes | The usefulness of anti-fucosylated antigen antibody YB-2 for diagnosis of hepatocellular carcinoma. |
| T2 | 100-360 | Sentence | denotes | Levels of fucosylated antigens in sera from patients with liver diseases were examined by a newly developed sandwich-type enzyme immuno assay with the aid of anti-fucosylated antigen antibody, YB-2 which reacts simultaneously with Y, Leb and H type 2 antigens. |
| T3 | 361-687 | Sentence | denotes | When the cut-off value was set arbitrarily at mean +3 SD values of normal, 30 (69.8%) of the 43 patients with HCC, 14 (53.8%) of the 26 patients with liver cirrhosis (LC) and 24 (45.3%) of the 53 patients with chronic hepatitis (CH) were found to be positive, whereas all of the 30 samples from healthy controls were negative. |
| T4 | 688-850 | Sentence | denotes | The levels of alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) in HCC were not correlated with those of YB-2 antigens. |
| T5 | 851-1121 | Sentence | denotes | The positive rates of the combination YB-2 and AFP assay and YB-2 and PIVKA-II assay in HCC were significantly higher (83.7 and 86.0%, respectively) than that of the AFP and PIVKA-II combination (65.1%) which had been reported to be the best combination up to this time. |
GlyCosmos15-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 74-98 | Disease | denotes | hepatocellular carcinoma | MONDO:0007256 |
| T2 | 158-172 | Disease | denotes | liver diseases | MONDO:0005154 |
| T3 | 511-526 | Disease | denotes | liver cirrhosis | MONDO:0005155 |
| T4 | 528-530 | Disease | denotes | LC | MONDO:0005155 |
| T5 | 571-588 | Disease | denotes | chronic hepatitis | MONDO:0002251 |
| T6 | 590-592 | Disease | denotes | CH | MONDO:0002251 |
GlyCosmos15-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 52-56 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | YB-2 | http://www.glycoepitope.jp/epitopes/AN0514 |
| T2 | 293-297 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | YB-2 | http://www.glycoepitope.jp/epitopes/AN0514 |
| T3 | 836-840 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | YB-2 | http://www.glycoepitope.jp/epitopes/AN0514 |
| T4 | 889-893 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | YB-2 | http://www.glycoepitope.jp/epitopes/AN0514 |
| T5 | 912-916 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | YB-2 | http://www.glycoepitope.jp/epitopes/AN0514 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 158-163 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
| T2 | 511-516 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
Anatomy-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 158-163 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/MAT_0000097 |
| T2 | 511-516 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/MAT_0000097 |